Notice on voluntary disclosure of approval for clinical trials of drugs obtained by Theoroni capsules for first-line treatment of widespread small-cell lung cancer

SZSI · Nov 2

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.